Mitochondria in Cancer Epidemiology, Detection, Diagnosis and Prognosis (R01) | Apply Online

Opportunity Summary:

The NIH funding opportunity PA-08-143, titled "Mitochondria in Cancer Epidemiology, Detection, Diagnosis and Prognosis (R01)," supports full-scale research projects aimed at improving how cancers are found, classified, and predicted using mitochondria-related biology. The central goal is to encourage R01 applications that develop and validate new biomarkers tied to mitochondrial function or mitochondrial alterations, with practical endpoints such as earlier cancer detection, more accurate diagnosis, better prognosis and risk assessment, and improved ability to monitor or predict response to preventive approaches or treatments that lessen disease burden. In other words, the emphasis is on mitochondrial measures that could realistically be used to inform cancer risk or patient management, not just basic mitochondrial observations without a clear biomarker path.

This announcement uses the NIH Research Project Grant (R01) mechanism, which generally fits larger, more comprehensive projects that can support substantial hypothesis-driven work, robust validation, and longer-term research plans. The FOA is paired with a parallel announcement of the same scientific scope, PA-08-144, which uses the R21 mechanism for exploratory or pilot studies. That pairing signals a pipeline: early, higher-risk concept testing can be pursued under the R21, while more mature ideas with stronger preliminary data and a clearer validation strategy are expected under the R01.

The scientific focus is mitochondria in relation to cancer epidemiology and clinically relevant outcomes. While the FOA text provided is brief, the intent is clear: applications should move beyond discovery alone and include development and validation of mitochondrial-related biomarkers. "Biomarkers" in this context can include molecular, genetic, genomic, functional, or biochemical indicators associated with mitochondrial DNA changes, mitochondrial damage, oxidative stress pathways, mitochondrial metabolism, or other mitochondria-linked mechanisms that correlate with cancer presence, progression, recurrence risk, or therapy response. The best-aligned projects would typically show how the proposed biomarker could be measured reliably (for example, in biospecimens or clinically obtainable samples), how it performs in distinguishing cases from controls or stratifying risk, and how it holds up under validation in independent populations or datasets.

Funding under this FOA is discretionary and contingent on the availability of funds and the number of high-quality applications received. The announcement does not guarantee a specific number of awards; instead, it indicates awards will be made if meritorious applications are submitted and NIH funds are available. There is no cost sharing or matching requirement, which is standard for many NIH research grants and reduces barriers for applicants who might not have non-federal matching funds.

Eligibility is broad and includes many organization types. Eligible applicants listed include public and private institutions of higher education, nonprofits (including those with 501(c)(3) status and certain nonprofits without it, with exclusions noted for institutions of higher education where applicable), for-profit organizations other than small businesses, and small businesses. Governmental entities such as state governments are eligible, and the FOA also allows additional categories including eligible federal agencies, U.S. territories or possessions, regional organizations, and non-U.S. entities (foreign organizations). This breadth suggests NIH is open to strong proposals from academic, governmental, nonprofit, and industry settings, including international collaborators or foreign-led projects, as long as they meet NIH requirements.

Administratively, the opportunity is categorized under health and cancer-related CFDA program areas, including cancer cause and prevention, detection and diagnosis, treatment, biology, and control. The opportunity was posted April 11, 2008, and the original and final closing date shown is May 7, 2011, with an archive date of June 7, 2011, indicating the announcement is no longer active but remains relevant as a reference point for similar NIH opportunities. The sponsoring agency is the National Institutes of Health, and the official full announcement was hosted on the NIH Grants Guide site. For access or technical issues, the contact listed is the NIH Office of Extramural Research (OER) webmaster email.

In practical terms, a competitive application under this FOA would typically be expected to lay out a clear biomarker development pathway: a biologically grounded rationale linking mitochondria to cancer-related endpoints, an assay or measurement strategy that can be standardized, and a rigorous validation plan that demonstrates performance characteristics like sensitivity, specificity, reproducibility, and clinical or epidemiologic relevance. The overall theme is translational value, aiming to turn mitochondrial insights into tools that can help detect cancer earlier, classify disease more accurately, predict outcomes more reliably, or guide prevention and treatment decisions.

Browse more opportunities from the same agency: National Institutes of Health

Browse more opportunities from the same category: Education Health

Next opportunity: Mitochondria in Cancer Epidemiology, Detection, Diagnosis and Prognosis (R21)

Previous opportunity: In Utero Exposure to Bioactive Food Components and Mammary Cancer Risk (R01)

USGrants.org Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for PA 08 143

 

[Watch] how do funding administrators access proposals?

Applicants also applied for:

Applicants who have applied for this opportunity (PA 08 143) also looked into and applied for these:

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Subscribe to Leads

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "PA 08 143", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.